Cystic Fibrosis: all 1,606 studies
Page 9 of 17. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.
- CFTR Modulator Effects on Bone and Muscle in Adults With Cystic FibrosisActive, not recruitingNCT04206436
- Effects of SIMEOX on Airway Clearance in Cystic FibrosisCompletedNCT04187924Not applicable
- Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis PatientsCompletedNCT04176328Phase 1
- Comparison of Different Functional Capacity Tests in Cystic Fibrosis Patients With Acute Pulmonary ExacerbationStatus unknownNCT04174664
- Mucoid Staphylococcus Aureus in Cystic Fibrosis AirwaysCompletedNCT04171583
- Comparison of the Efficacy of Comprehensive Respiratory Physiotherapy in Children With Cystic Fibrosis and Non-Cystic Fibrosis BronchiectasisCompletedNCT04170114Not applicable
- Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic FibrosisCompletedNCT04166396Early Phase 1
- Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With CF, PCD and Healthy ChildrenCompletedNCT04161313
- Exercise With or Without Electrical Stimulation in Cystic Fibrosis (Part I): Effects on Physical FitnessCompletedNCT04153669Not applicable
- Effect of Lumacaftor/Ivacaftor in Children With Cystic Fibrosis Homozygote for F508del on Small Airway FunctionCompletedNCT04138589
- A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X AlleleCompletedNCT04135495Phase 2
- Parenting Concerns in Patients With Cystic Fibrosis (MucoPar)CompletedNCT04133246Not applicable
- A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X AlleleCompletedNCT04126473Phase 2
- Acceptance and Commitment Therapy vs. Supportive Psychotherapy With Cystic Fibrosis PatientsCompletedNCT04114227Not applicable
- Home Airway Clearance in CF PatientsCompletedNCT04096664Not applicable
- Ancillary Home Airway Clearance in CF Patients ( HomeCareSIMEOX )CompletedNCT04095078Not applicable
- Modeling of Chest Physiotherapy Using Impedance Measurements (PHYSIOMOD)CompletedNCT04094441Not applicable
- Feasibility of a New Model for Exercise Prescription in Cystic FibrosisCompletedNCT04075864Not applicable
- Evaluating the Alimentary and Respiratory Tracts in Health and Disease (EARTH) Research Program.Status unknownNCT04071314
- Measuring and Improving Coproduction Using coopeRATETerminatedNCT04060329Not applicable
- Clinical Utility of the 1-minute Sit to Stand Test as a Measure of Submaximal Exercise Tolerance in Patients With Cystic Fibrosis During Acute Pulmonary ExacerbationCompletedNCT04058548Not applicable
- Taste Receptors Regulation in CF PatientsStatus unknownNCT04058340Not applicable
- VX-445/TEZ/IVA Expanded Access Program for Cystic Fibrosis (CF) Patients Heterozygous for F508del Mutation and a Minimal Function Mutation (F/MF Genotypes)Approved for marketingNCT04058210
- Impact of Triple Combination CFTR Therapy on Sinus Disease.Status unknownNCT04056702
- Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.CompletedNCT04038710
- A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR FunctionCompletedNCT04038047
- Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic FibrosisCompletedNCT04024423
- Clinical Impact of MI on Inhaled Antibiotic Adherence in Cystic FibrosisCompletedNCT04017559Not applicable
- Parameters to Assess Response to Intra-Venous Antibiotic Treatment for Pulmonary Exacerbations in Cystic FibrosisCompletedNCT04016571
- Prediction of Survival in Children With Cystic Fibrosis Using the Multiple-breath WashoutCompletedNCT04016194
- A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated Inhalation in Patients With Cystic Fibrosis (CF) and in Patients With Non Cystic Fibrosis (NCFB) BronchiectasisCompletedNCT04010799Phase 1
- Impact of Bronchial Drainage Technique by the Medical Device Simeox® on Respiratory Function and Symptoms in Adult Patients With Cystic FibrosisCompletedNCT04010253Not applicable
- Gut Imaging for Function & Transit in Cystic Fibrosis Study 2CompletedNCT04006873Phase 2
- New Markers of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Function in SweatStatus unknownNCT03993600Not applicable
- HFNT During Exercise in CFCompletedNCT03965832Not applicable
- Glycemic Characterization and Pancreatic Imaging Correlates in Cystic FibrosisCompletedNCT03961516
- Functional Respiratory Imaging and Orkambi in CFTerminatedNCT03956589Phase 4
- PREMO Study: to Investigate Port REMoval OutcomesCompletedNCT03948958Not applicable
- Microbial Biomarkers of EArly Pseudomonas Aeruginosa Colonization in CHildren With Cystic FibrosisActive, not recruitingNCT03947957Not applicable
- Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD ManagementTerminatedNCT03939065Not applicable
- Thermic Effect of Feeding in Cystic FibrosisWithdrawnNCT03931252Not applicable
- A Study to Evaluate Safety and Efficacy of Subcutaneous Administration of Anakinra in Patients With CFTerminatedNCT03925194Phase 2
- Tele-Coaching Intervention to Improve Treatment Adherence in Cystic FibrosisCompletedNCT03921229Not applicable
- ECMO for Lung Transplantation in Cystic Fibrosis PatientsCompletedNCT03919604
- Efficacy of a New Sweat Collection Support: Impact on Neonatal Screening and Early Treatment of Cystic FibrosisCompletedNCT03913507Not applicable
- Epidemiology of the Nasal Flora at the Reference Center for Cystic Fibrosis of Queen Fabiola Children's University Hospital.Status unknownNCT03911258Not applicable
- Cross Transmissions of Pseudomonas Aeruginosa Between Children From a Same Cystic Fibrosis Center.Status unknownNCT03910920
- Technology-enabled Patient Support System for Self-management of CFCompletedNCT03910881Not applicable
- Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF BronchiectasisStatus unknownNCT03903913Phase 2
- Reaction Time and Postural Control in Individuals With Cystic Fibrosis and BronchiectasisStatus unknownNCT03902236
- Validation of Respiratory Epithelial Functional Assessment to Predict Clinical Efficacy of Orkambi®.CompletedNCT03894657Not applicable
- Gynecological Health Improvement of Adult Women With Cystic FibrosisCompletedNCT03892304
- Pulsed Radiofrequency for Chronic Mastalgia of Fibrocystic Disease of the BreastStatus unknownNCT03888963Not applicable
- Implication of UNconventionaL T Lymphocytes in Cystic Fibrosis (UNLOCk)CompletedNCT03886350
- Effects of Expiratory Muscle Training on Cough Efficacy in Children and Adolescents With Cystic FibrosisCompletedNCT03873688Not applicable
- The Effect of PC945 on Aspergillus Fumigatus Lung Infection in Patients With Cystic FibrosisTerminatedNCT03870841Phase 2
- Gastrointestinal Study at Orkambi Therapy in CF PatientsStatus unknownNCT03859531
- Air Pollution and Children With Cystic FibrosisCompletedNCT03853629
- Educational Program Through Video Conference for Inhaled Therapies in Cystic Fibrosis PatientsCompletedNCT03850145
- Cystic Fibrosis and Fit-to-FlyCompletedNCT03843723
- PatientSpot Formerly Known as ArthritisPowerStatus unknownNCT03840928
- A Phase 2b Randomised, Placebo Controlled Study of OligoG in Patients with Cystic FibrosisTerminatedNCT03822455Phase 2
- Vaccination Coverage and Level of Protection in Patients at RiskCompletedNCT03820752
- Cystic Fibrosis and Cognitive FunctionCompletedNCT03820349
- WGS of Korean Idiopathic BronchiectasisStatus unknownNCT03809091
- Effect of a Family Empowerment Program on Coping, Problem Solving in Parents, and Quality of Life in Children With Cystic FibrosisCompletedNCT03800459Not applicable
- Orkambi Treatment in 2 to 5 Year Old Children With CFCompletedNCT03795363
- Ivacaftor Treatment in 4 Month to 2 Year Old CF SubjectsCompletedNCT03783286
- Evaluation of a Behavioural Intervention Using App Technology in CFCompletedNCT03782909Not applicable
- Pharmacokinetic and Pharmacodynamic Analysis of Ceftaroline in Children and Adolescents With Cystic FibrosisCompletedNCT03771313
- Short-term Effects of Physiotherapy on LCICompletedNCT03760120Not applicable
- A DDI Study of FDL169 and FDL176 in Healthy SubjectsSuspendedNCT03756922Phase 1/2
- In Vitro Model of the Cystic Fibrosis Bronchial Epithelium Via iPS TechnologyCompletedNCT03754088
- Estimated Impact of Fungal Colonization in Cystic Fibrosis From Secondary Exploitation of MucoFong Database.CompletedNCT03753828
- Clinical Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of POL6014 in Patients With CFCompletedNCT03748199Phase 1/2
- Inspiratory Muscle Training in Individuals With Cystic FibrosisCompletedNCT03737630Not applicable
- Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis PatientsCompletedNCT03736096
- PK/PD of Vitamin D3 in Adults With CFTerminatedNCT03734744Not applicable
- Validation of a Predictive Score for HASTCompletedNCT03728595
- Pilot E2 for Hypogonadal Women With CFBDWithdrawnNCT03724955Phase 4
- The Effect of a Pre-meal Snack and/or Exercise on Post-prandial Glycemic Excursions in Adults With Cystic FibrosisCompletedNCT03710538Not applicable
- Resting Energy Expenditure in Patients With Cystic Fibrosis: A Pilot StudyTerminatedNCT03699982Not applicable
- A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic FibrosisWithdrawnNCT03698448Phase 2/3
- Sputum Validation for the Molecular Diagnosis of Respiratory Viral Infections in Cystic FibrosisCompletedNCT03684759
- Study of Peripherally Inserted Venous Catheters in Cystic Fibrosis PatientsCompletedNCT03674216
- Steps Ahead: Optimising Physical Activity and Health in Adults With Cystic FibrosisCompletedNCT03672058Not applicable
- SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis SubjectsStatus unknownNCT03669614Phase 1/2
- Impact of the Introduction of ORKAMBI on Anxiety, Depression, Quality of Life and Adherence of Adolescents and Young AdultsCompletedNCT03659214
- Effects of AD on VI in Patients With CFWithdrawnNCT03655249Not applicable
- Early Check: Expanded Screening in NewbornsActive, not recruitingNCT03655223
- Effects of Aerobic Interval Training on Glucose Tolerance in Children and Adolescents With Cystic FibrosisStatus unknownNCT03653949Not applicable
- Human Papilloma Virus Vaccination in Girls With Cystic Fibrosis (VACCIN-HPV-MUC2)CompletedNCT03653377
- Primary Nasal Cell Culture as a Tool for Personalized Therapy in Cystic FibrosisCompletedNCT03652090
- EnVision CF Multicenter Study of Glucose Tolerance in Cystic FibrosisCompletedNCT03650712Not applicable
- A Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of IONIS-ENaCRx in Healthy Volunteers and Patients With Cystic FibrosisCompletedNCT03647228Phase 1
- Evaluation of Device Settings for Airway Clearance Using The Monarch Airway Clearance SystemStatus unknownNCT03645473Not applicable
- Development of Diabetes in Adults With Cystic Fibrosis (CF)WithdrawnNCT03644199Not applicable
- Feasibility of a Mobile Medication Plan Application in CF Patient CareCompletedNCT03637504Not applicable
- Developing e-Health Systems to Improve Growth and Nutrition in CFCompletedNCT03635762Not applicable
- Intravenous Iron in Adults With Cystic FibrosisCompletedNCT03632525Phase 4